MTF acquires PRP & PRFM technologies from Cascade Medical Enterprises

  
 
Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business (press release)
WAYNE, N.J., Jan. 6, 2012 /PRNewswire/ -- Cascade Medical Enterprises, LLC (CME), a leading company with proprietary platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM) technology for use in orthopedic therapeutic applications in soft tissue and bone repair, announced the sale of their technology to Musculoskeletal Transplant Foundation (MTF) and distribution by ConMed Linvatec for the worldwide orthopedic, dental, and wound care markets.
CME has had a long collaborative US ...